4//SEC Filing
Tregoning Kathleen 4
Accession 0000950170-23-073592
CIK 0001805387other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 4:15 PM ET
Size
6.9 KB
Accession
0000950170-23-073592
Insider Transaction Report
Form 4
Tregoning Kathleen
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2023-12-26$10.05/sh+3,150$31,658→ 10,666 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-26−3,150→ 255,082 totalExercise: $10.05Exp: 2030-07-29→ Common Stock (3,150 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option vested and became exercisable on July 28, 2021, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001830764
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 4:15 PM ET
- Size
- 6.9 KB